Target intelligence / Profile preview

Ferredoxin-2, mitochondrial (FDX2)

Target
FDX2
Molecular classification
Iron-sulfur protein, Electron transfer protein, Mitochondrial protein, Other
01

Overview

Ferredoxin-2, mitochondrial (FDX2) is a small iron-sulfur protein located in the mitochondrial matrix that serves as an indispensable electron donor to the iron-sulfur cluster (ISC) assembly machinery, supporting de novo Fe/S cluster biosynthesis essential for the maturation of numerous mitochondrial and cellular Fe/S proteins[1][2][5]. Structurally, it is a [2Fe-2S] protein that binds and donates electrons specifically for Fe/S protein biogenesis and heme A synthesis, but does not participate in steroidogenesis (unlike FDX1)[1][5]. Genetic defects in FDX2 can lead to mitochondrial disease including myopathies and neuropathies due to the failure of essential mitochondrial functions[1]. FDX2 is not generally considered a drug target but is a component essential for core mitochondrial metabolism[1][4].

Other names
Ferredoxin-2FDX2FDX1LAdrenodoxin-like proteinFerredoxin-1-like proteinMGC19604MEOALFerredoxin 1 likeFerredoxin-2, mitochondrialAdrenodoxin-like protein, mitochondrial
02

Mechanism of action

Inhibition of electron transfer required for Fe/S cluster biogenesis (for elesclomol)

03

Biological functions

Iron-sulfur (Fe/S) cluster biogenesisElectron transferHeme A biosynthesisCellular respirationMitochondrial Fe/S protein maturation
04

Disease associations

Mitochondrial myopathySensory neuropathyOther (disruption causes severe genetic mitochondrial diseases but not directly implicated in classical disease categories such as cancer or infection)
05

Interacting drugs

Elesclomol

Beyond the preview

Go deeper on Ferredoxin-2, mitochondrial (FDX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferredoxin-2, mitochondrial (FDX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call